Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/10519403

Cancer Res. 1999 Oct 1 59 19 4906-11

Download in:

View as

General Info

PMID
10519403